Analyst Dara Mohsenian from Morgan Stanley maintained a Buy rating on Keurig Dr Pepper and keeping the price target at $40.00.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Dara Mohsenian has given his Buy rating due to a combination of factors including Keurig Dr Pepper’s solid organic sales growth (OSG) and maintained full-year earnings per share (EPS) guidance. The company’s recent performance, particularly in the coffee segment, shows signs of recovery, with sales stabilizing after a period of decline. This improvement, alongside favorable pricing dynamics, suggests a positive outlook for future growth.
Furthermore, the valuation of Keurig Dr Pepper appears attractive, trading at a discount compared to its peers despite its strong sales performance. Mohsenian believes that the company’s ability to manage costs and maintain pricing power, even in the face of rising coffee costs and tariffs, positions it well for continued success. The potential for 19% upside in the stock price further supports the Buy recommendation.
In another report released yesterday, TR | OpenAI – 4o also reiterated a Buy rating on the stock with a $37.00 price target.
Based on the recent corporate insider activity of 46 insiders, corporate insider sentiment is neutral on the stock.